- Post-Effective Amendment to Registration Statement (POS AM)
18 9월 2009 - 12:46AM
Edgar (US Regulatory)
Registration
No. 333-66554
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-3
REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933
NYER
MEDICAL GROUP, INC.
(Exact Name of Registrant
as Specified in Its Charter)
Florida
|
|
04-0469607
|
(State or Other
Jurisdiction of Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
13 Water Street
Holliston, Massachusetts 01746
(508)
429-8506
(Address, including zip code, and telephone
number, including area code, of registrants principal executive offices)
Mark
Dumouchel, President
Nyer
Medical Group, Inc.
13 Water Street
Holliston, Massachusetts 01746
(508) 429-8506
(Name, address, including zip code, and
telephone number, including area code, of agent for service)
Copy
to
:
Howard
E. Berkenblit, Esq.
Sullivan &
Worcester LLP
One Post
Office Square
Boston,
Massachusetts 02109
(617)
338-2800
Approximate date of commencement of proposed sale
to the public:
Not
applicable.
If the only securities being registered on this form
are being offered pursuant to dividend or interest reinvestment plans, please
check the following box.
o
If any of the securities being registered on this Form are
to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, other than securities offered only in connection
with dividend or interest reinvestment plans, check the following box.
o
If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the
Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering.
o
If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering.
o
If this Form is a registration statement pursuant
to General Instruction I.D. or a post-effective amendment thereto that shall
become effective upon filing with the Commission pursuant to Rule 462(e) under
the Securities Act, check the following box.
o
If this Form is a post-effective amendment to a
registration statement filed pursuant to General Instruction I.D. filed to
register additional securities or additional classes of securities pursuant to Rule 413(b) under
the Securities Act, check the following box.
o
DEREGISTRATION
OF UNSOLD SHARES OF COMMON STOCK
On August 2, 2001, Nyer Medical Group, Inc.
(the Company) filed a Registration Statement on Form S-3 (Registration No. 333-66554)
(the Registration Statement) for resales of an aggregate of 15,873 shares of
common stock, par value $.0001 per share, of the Company. This Post-Effective Amendment No. 1 is
being filed by the Company pursuant to the Companys undertaking in accordance
with the Registration Statement to deregister all 15,873 shares of common stock
registered pursuant to the Registration Statement, or such lesser portion that
have not been sold or transferred pursuant to the Registration Statement as of
the date this Post-Effective Amendment No. 1 is filed. The contractual obligations between the
Company and the selling securityholder named in the Registration Statement
requiring the Registration Statement to remain effective have expired by their
terms.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of
1933, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-3, and has duly
caused this Post-Effective Amendment No. 1 to the Registration Statement
to be signed on its behalf by the undersigned, thereunto duly authorized, in
the City of Holliston, Commonwealth of Massachusetts, as of the 17
th
day of
September, 2009.
|
Nyer Medical Group, Inc.
|
|
|
|
|
|
By:
|
/s/ Mark Dumouchel
|
|
|
Name:
|
Mark Dumouchel
|
|
|
Title:
|
President and Chief Executive Officer
|
Pursuant to the requirements of the Securities Act
of 1933, as amended, this Post-Effective Amendment No. 1 to the
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
/s/ David Dumouchel
|
|
Director
|
|
September 17, 2009
|
David Dumouchel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Robert J. Landis
|
|
Director
|
|
September 17, 2009
|
Robert J. Landis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ James Schweiger
|
|
Director
|
|
September 17, 2009
|
James Schweiger
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Gerald Weston
|
|
Director
|
|
September 17, 2009
|
Gerald Weston
|
|
|
|
|
3
Nyer Medical (NASDAQ:NYER)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Nyer Medical (NASDAQ:NYER)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024